Atopic Dermatitis

Although food allergy appeared common among children with atopic dermatitis, only 3% had food-triggered atopic dermatitis, according to a study published in The Journal of Allergy and Clinical Immunology: In Practice.

Patients with asthma, chronic rhinosinusitis with nasal polyps and atopic dermatitis experienced transient increases in eosinophil counts following treatment with dupilumab, according to study results.

Long-term treatment with Dupixent was well-tolerated and showed incremental benefit with continued treatment for atopic dermatitis, consistent with results from short-term treatment.

CLEVELAND — In this video from the Medical Dermatology Therapy Update II meeting, Amy S. Paller, MD, professor and chair of dermatology at Northwestern University, discusses new therapies on the horizon for atopic dermatitis.

Clinicians should consider potentially harmful ingredients such as haptens when using moisturizing emollients to prevent atopic dermatitis or food allergy, according to a review published in Clinical and Translational Allergy.

Lebrikizumab monotherapy was efficacious in improving atopic dermatitis in 80% of patients at 1 year, according to results from two phase 3 trials announced by Eli Lilly and Company.

The FDA has extended the approval of Dupixent to include children aged 6 months to 5 years with moderate to severe atopic dermatitis, Regeneron Pharmaceuticals and Sanofi announced in a press release.

For some atopic dermatitis patients treated with tralokinumab who do not reach clear or almost clear skin, clinically meaningful results can still occur.

Depressive episodes are closely correlated with and fluctuate with atopic dermatitis severity, according to details from a study published in the Journal of the American Academy of Dermatology.

Patients with atopic dermatitis, especially those with more severe forms of the disease, are at increased risk for multiple autoimmune conditions, according to a study published in The Journal of Allergy and Clinical Immunology.